Advertisement
New Zealand markets closed
  • NZX 50

    11,938.08
    +64.04 (+0.54%)
     
  • NZD/USD

    0.6041
    +0.0079 (+1.32%)
     
  • NZD/EUR

    0.5593
    +0.0037 (+0.67%)
     
  • ALL ORDS

    7,897.50
    +48.10 (+0.61%)
     
  • ASX 200

    7,629.00
    +42.00 (+0.55%)
     
  • OIL

    79.03
    +0.08 (+0.10%)
     
  • GOLD

    2,309.50
    -0.10 (-0.00%)
     
  • NASDAQ

    17,541.54
    +222.99 (+1.29%)
     
  • FTSE

    8,228.90
    +56.75 (+0.69%)
     
  • Dow Jones

    38,225.66
    +322.37 (+0.85%)
     
  • DAX

    18,066.59
    +170.09 (+0.95%)
     
  • Hang Seng

    18,475.92
    +268.79 (+1.48%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • NZD/JPY

    91.9030
    +0.3280 (+0.36%)
     

The Bad News Heading Into AbbVie's First-Quarter Earnings Report

The Bad News Heading Into AbbVie's First-Quarter Earnings Report

AbbVie stock has slumped 9% off its record high in March and is facing increasingly steep competition for its biggest moneymaker, Humira.